CD274 and neoplasm: These data suggest that B10G5 co-targeting sMIC likely restores NK homeostatic maintenance and thus NK cell-mediated anti-tumor immunity through regulating the availability of IL-2 and sensitivity of IL-2 signaling on NK cells, as compared to anti-PDL1 single agent therapy.